 |
|
Angela Veloudios, MD, FACS
Angela Veloudios, MD, FACS is a Fellow of the prestigious American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), one of only approximately 400 surgeons nationally who has received certification for this subspecialty of ophthalmology. Dr. Veloudios is also a Fellow of the American College of Surgeons (F.A.C.S.) She has published numerous journal articles on various topics in her subspecialty.� Dr. Veloudios is an attending surgeon at Wills Eye Surgery Center, Cooper University Medical Center, Virtua Memorial, and Lourdes Medical Center of Burlington County.
  Articles by this Author
Patients are seeking a longer lasting product that fills in lines, such
as the lines around the mouth, as part of their overall anti-aging skin
care regimen. Dermal fillers such as Juvèderm™ injectable gel are
designed to reduce the appearance of facial folds by using hyaluronic
acid (HA), a naturally hydrating substance, to restore the skin’s volume
and smooth out the wrinkles and folds on your face. A long lasting,
reversible filler such as Juvèderm™ can provide a natural look which can
be modified or adjusted according to each individual’s face over time.
New clinical studies have shown that the effects of this product may
last up to one year with a single treatment.
Ophthalmologists are once again at the forefront of innovation for cosmetic facial procedures.
Overview of JuvPatients are seeking a longer lasting product that fills in lines, such as the lines around the mouth, as part of their overall anti-aging skin care regimen.
Ophthalmologists are once again at the forefront of innovation for cosmetic facial procedures. From Botox® to Juvéderm®, eye physicians have been regarded as the experts in the original research and development of injectable, anti-wrinkle treatments.
Ophthalmologists are once again at the forefront of innovation for cosmetic facial procedures. From Botox® to Juvéderm®, eye physicians have been regarded as the experts in the original research and development of injectable, anti-wrinkle treatments. Now, Latisse™, the first and only FDA-approved treatment for inadequate or sparse, thinning eyelashes, has been added to the options for facial enhancement.
Patients are seeking a longer lasting product that fills in lines, such
as the lines around the mouth, as part of their overall anti-aging skin
care regimen.
Ophthalmologists are once again at the forefront of innovation for
cosmetic facial procedures. From Botox® to Juvéderm®, eye physicians
have been regarded as the experts in the original research and
development of injectable, anti-wrinkle treatments. Latisse™, the first and only FDA-approved treatment for inadequate or
sparse, thinning eyelashes, has been added to the options for facial
enhancement.
Ophthalmologists are once again at the forefront of innovation for
cosmetic facial procedures. From Botox® to Juvéderm®, eye physicians
have been regarded as the experts in the original research and
development of injectable, anti-wrinkle treatments. Now, Latisse™,
the first and only FDA-approved treatment for inadequate or sparse,
thinning eyelashes, has been added to the options for facial
enhancement. Its origin is directly from a glaucoma medication that
ophthalmologists have been using for the treatment of elevated eye
pressure.
Patients are seeking a longer lasting product that fills in lines, such
as the lines around the mouth, as part of their overall anti-aging skin
care regimen.
Patients are seeking a longer lasting product that fills in lines, such as the lines around the mouth, as part of their overall anti-aging skin care regimen.
Blogs by this Author
|
|
| |
|
Categories
No categories found.
No popular authors found.
No popular articles found.
|
